ABSTRACX. We determined if reducing litter number by selective fetal ablation (A) might enhance the growth of the surviving fetuses. On day 14 of the rat's 21.5-day gestation, we ligated branches of the uterine artery at their secondary division. Each of these branches supplies a placenta and its fetus, and ligation kills them. Every other fetus in litters of eight to 14 fetuses was ablated. Each A maternal rat was matched to a control with an equal number of fetuses. Ablation reduced fetal number (from 8-14 to 4-7) and increased fetal growth (birth weight 5.84 f 0.05 versus 5.20 f 0.05 g, p < 0.001). In the A but not control litters, newborn body mass was negatively related to litter number. Fetuses of A litters had increased carcass, liver, and brain mass. On days 18 and 19, fetal plasma glucose concentrations, fetallmaternal glucose ratios, insulin concentrations, and hepatic glycogen concentrations were increased suggesting that A increases glucose provision to the surviving fetuses. Although these observations imply that A enhances glucose provision resulting in stimulated growth of insulin-sensitive tissues, the growth of the brain, purportedly a tissue not sensitive to insulin, was also increased. In addition, the growth rate of A fetuses continued to be increased on days 20 and 21 despite normal fetal plasma glucose and insulin. These observations indicate that with A, factors other than insulin also stimulated growth. Of note, newborn A pups developed hypoglycemia at 20 and 60 min as a result of increased insulin secretion. Newborn A pups also failed to increase hepatic cytosolic phosphoenolpyruvate carboxykinase. Selective uterine artery ligation is reproducible, relatively easy to implement, and may prove to be useful for studying the phenomenon of accelerated fetal growth. The determinants of fetal growth are numerous and not completely delineated. Glucose and amino acid availability and fetal insulin secretion are important to stimulate and sustain fetal growth (1, 2) . Less is known about the effects of physical factors such as litter number and uteroplacental blood flow, and few animal models are available to assess the effects of these variables on intrauterine growth. In normal litters of polytococcous animals, the number of fetuses in a litter is roughly inversely related to birth weight (3, 4) . Whereas reducing litter number by such means as aspiration (5) or electrocautery (6) may enhance the growth of the remaining fetuses, these techniques have not been assessed in a systematic manner.
In the human, being excessively large at birth greatly increases the risk of birth trauma (7) and is associated with such morbidities as hypoglycemia (8) . To better understand the mechanisms responsible for fetal growth, a reproducible method for accelerating intrauterine growth would be desirable. We have devised a method to accelerate intrauterine growth in the rat that involves ligation of the secondary uterine arteries during late gestation. This kills the fetuses supplied by these vessels and enhances the growth of the remaining fetuses. Although the mechanisms for stimulating intrauterine growth are not absolutely clear, the accelerated growth of fetuses is to some extent related to enhanced glucose availability with consequent stimulation of fetal insulin secretion.
MATERIALS AND METHODS

Surgery.
We used pregnant Sprague-Dawley rats who had a prepregnancy weight of 170-190 g (Harlan Laboratories, Madison, WI). Gestation was timed to within 6 h of mating. On day 14 of their 21.5-day gestation, we anesthetized the rats with intraperitoneal chloral hydrate (35 mg/100 g body weight) and with aseptic technique exposed each horn of the uterus with special attention to the branches of the uterine artery. In the rat, the uterine artery is a loop fed at the top from the abdominal aorta on the right and renal artery on the left and at the bottom from the iliac arteries. Figure 1 details the distribution of an uterine artery. The arteries originating from the main artery undergo several generations of branching. An artery after the second branching leads directly to the -region of the uterus overlying the placenta of a fetus and serves as their blood source. We ligated the arterial branch at this point with 4-0 silk suture. Arteries to every other fetus in both uterine horns were ligated in this manner. In successive rats we alternated the ligation sequence by beginning with either the arteries to the uppermost or the second highest fetuses in a horn. We used onlv rats with eight to 14 fetus&. For controls, we matched each rat undergoing ligation to a rat with an equivalent number of fetuses. The uterine horns of the control rats were exposed and manipulated to the same extent as the experimental animals but no ligation was performed. We closed the abdominal musculature with 4-0 chromic suture and the skin with wound clips. The entire procedure required 10-15 min and rats were awake within 1 h of initiation of anesthesia. Before and after surgery, maternal rats had ad libitum access to food (Purina Rat Chow, Purina, St. Louis, MO) and water. In other experiments, we used the same ligation method in rats at other points (days 11-13 and 15-20) in gestation. In three other groups of mothers on day 14 we ligated arteries to I) all but one fetus, 2) two to three fetuses/ entire litter, or 3) a single fetuslentire litter. Control rats were subjected to sham ligation in each of these experiments. Fetal sampling. On days 18 to 2 1, we used the method of Girard et al. (9) to obtain blood from each fetus with the fetalplacental circulation intact. We could not collect individual fetal blood samples in sufficient quantity for analysis before day 18. The mother was anesthetized with pentobarbitol (5 mg/100 g body weight) and the uterus exposed and sequentially incised so that individual fetuses could be carefully removed leaving the placenta attached to the uterine wall. The fetuses were dried and maintained at 37" C (with heat lamps and warm moist gauze) and care was taken to apply minimal tension to the umbilical cord. Blood was obtained from axillary vessels within 10-15 s of cutting. The volume was sufficient for determining glucose and hormone concentrations for each fetus. Maternal blood was obtained simultaneously from tail veins so that maternal-fetal glucose ratios could be calculated. After blood sampling the fetus was killed by decapitation and the liver quickly removed and frozen in liquid nitrogen. Hepatic glycogen content and cytosolic PEPCK activity were measured for each fetus and pup. In some animals we did not sample blood but quickly froze the fetal liver as soon as the fetus was removed from the uterus. Hepatic glycogen concentrations and cytosolic PEPCK activities from these fetuses did not differ from those who underwent blood sampling before freezing the liver. We also determined DNA and protein content in brain and liver. We sampled from only the first two to three fetuses in a litter to avoid any potential effect of prolonged maternal anesthesia. Preliminary studies indicated that plasma glucose and insulin concentrations from these fetuses did not differ from values of fetuses in other positions in the uterus. A total of 20 to 25 litters comprised each group at each day of gestation.
Neonatal sampling. On day 21.5, we delivered rat pups by cesarean section after stunning and cervical dislocation of the mother. As in previous studies, pups were quickly dried, separated from their placentas, and placed in chambers that provided humidified air at 37°C. Pups had blood collected from severed axillary vessels and were then decapitated. We measured in sequential littermates plasma glucose, insulin, glucagon, and hepatic glycogen concentrations and PEPCK activity during the first 240 min of life. DNA and protein concentrations in brain and liver were obtained from other pups immediately at birth. Each group was comprised of 30 to 35 litters. Data at each time point for a group represent at least 30 pups.
Analyses. Plasma glucose concentrations were determined for each fetus and pup (Beckman 11, Glucose Analyzer). Blood for hormone analysis was treated with Aprotinin (Trasylol25: 1 vol/ vol) and the plasma frozen at -70" C until assay. We have reported the details of our analytical methods (10, 11) . Both plasma insulin and glucagon concentrations were determined with double antibody radioimmunoassays with rat insulin (Novo Laboratories, Copenhagen, Denmark) and porcine glucagon (Eli Lilly, Indianapolis, IN) respectively as standards. Samples of 25-p1 were used for insulin and 50 for glucagon determinations. For the insulin assay, the minimum detectable mass was 0.78 pU/assay tube and the coefficients of interassay and intraassay variation of rat plasma pool samples were 10.5 and 2.3%. For glucagon, the minimum detectable mass was 7.7 + 2.0 pg/assay tube, and coefficients of interassay and intraassay variation of rat plasma pool samples were 15.8 and 11.5%, respectively. Hepatic cytosolic PEPCK activity and glycogen concentrations and tissue DNA and protein concentrations were determined as established in our laboratory. Mixed arteriovenous blood gas tensions and pH were determined with an ILC 1301 automated blood gas analyzer.
Fetuses and pups were dissected to obtain liver, kidneys, stomach and intestine, spleen, heart, carcass (muscle, skin, adipose tissue, and skeletal bones), and brain (cerebral hemispheres to midbrain). Organs and placentas were blotted dry and drained of as much blood as possible before weighing. Organs were also weighed after 12 h drying in an 40" C oven. Livers for biochemical measurements were quickly removed, weighed, cut into pieces, frozen in liquid nitrogen, and stored at -70" C.
Statistical analysis was performed using the Student's unpaired t test for comparison of values between groups and paired t tests for values within groups (12) . Analyses were performed on a Cyber 170-780 computer at the Vogelback Computer Center of Northwestern University. Data are presented as the mean + SEM. This protocol was approved by the Animal Care Committee of Northwestern University Medical School.
RESULTS
General. In 7% of maternal rats in whom ligation was performed on day 14, fetuses were lost as a result of abortion, hemorrhage, or infection. In the remaining animals, ligation of every other artery on day 14 consistently resulted in a 50% reduction in litter size (from 8-14 to 4-7) and enhanced the growth of the remaining fetuses and placentas. We found no differences in litter restriction or growth effect between litters in which arteries were ligated to the uppermost or second highest fetus in a horn. The letter A designates the fetuses and pups who remained after selective ligation because they demonstrated accelerated growth after ablation of littermates. None of the A litters had spontaneous reabsorption of fetuses and three of 100 control litters had resorption of one fetus between days 14 and term.
The effect on fetal growth was less reproducible when ligation was performed on days other than day 14. When ligation was performed on days 11 to 13, several rather than a single fetus were killed with each ligation and the growth of the surviving fetuses was not consistently increased. Thirty percent of mothers aborted. Ligation on days 15 to 20 never increased fetal growth. When more than 50% of secondary vessels were ligated on day 14, there was a 60-70% loss rate in the fetuses whose arteries had not been ligated. The growth rate of the surviving fetuses was not greater than that of A fetuses in which 50% litter reduction had been performed. Albation of fewer than 50% of fetuses on any day of gestation caused inconsistent growth patterns in the remaining fetuses. Single artery ligation resulting in the death of one fetus had no effect upon the growth of the remaining fetuses.
Growth. Within 4 h of ligation on day 14, fetuses whose uterine artery branches had been tied were dead. On days 16 and 17,
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OGATA AND FINLEY autolyzing fetal and placental tissue was still discernible within the amniotic membranes. By day 18, only a small nubbin of coalesced tissue remained. Control and A fetuses and placentas were of similar weight from days 14 to 17. From day 18 until birth, A fetuses and placentas were significantly heavier than controls. The rate of growth A fetuses was greater than that of controls (1.50 f 0.15 versus 1.00 + 0.14 g/day, p < 0.001) and was constant between days 18 and 21 (Fig. 2) On days 14 to 17, organ weight did not differ between A and control fetuses. From day 18 onward, brain, liver, and carcass mass of A fetuses significantly exceeded control values (Fig. 3) The mass of heart, kidneys, spleen, and gastrointestinal tract did not differ between groups. Comparison of wet and dried tissue indicated that water comprised 75 to 80% of fetal body mass and did not differ between groups. From day 18 until term, DNA and protein concentrations in the brain and liver of A fetuses and pups were significantly increased compared to controls.
Newborn A pups had brain DNA concentrations of 4.52 + 0.10 pg/g brain whereas control pups had 3.38 f 0.09 pg/g brain.
Respective protein concentrations were 60.5 + 1.6 and 52.8 + 1.0 mg/g brain. Hepatic DNA concentrations were 3.62 + 0.04 pg/g liver in A pups and 3.35 f 0.05 pg/g liver in control pups.
Protein concentrations were 62.5 k 2.6 mg/g liver and 53.7 + 1.8 mg/g liver in A and control pups. All four sets of variables were significantly different between groups ( p < 0.00 1 level).
Litter number and fetal body mass were inversely related in A but not control groups. When linear regression analysis was used to relate mean newborn body mass to the number of pups in a litter for A animals, a significant association was apparent (r = 0.789 n = 151, p < 0.001). In addition, to eliminate potential litter bias, we chose at random a single newborn from each litter and related its body mass to the number of pups in its litter. This too demonstrated a significant relationship (Fig. 4) . Similar associations were apparent when a specific fetus (e.g. the second in the right horn of each litter) was related to litter number. The mean body mass of A pups in litters originally 12 to 14 reduced to six and seven was significantly greater than pups of control litters of 8 (5.48 f 0.05 versus 5.28 f 0.05, p < 0.01). The relation between body mass and litter number was also significant when A and control litters were considered together although to a lesser degree than when A litters were considered alone. We could not identify any consistent pattern between a fetus' position in a uterine horn with body or placental mass.
Fetal metabolism. On days 18 and 19, A fetuses had significantly elevated plasma glucose and insulin and diminished glucagon concentrations compared to controls. On days 20 and 2 1, fetal plasma glucose, insulin, and glucagon concentrations were equivalent in A and control fetuses. Maternal glucose concentrations did not differ between A and control mothers at any point; thus fetal/maternal glucose ratios were significantly elevated in A fetuses on days 18 and 19 ( Neonatal metabolism. At birth, A pups had plasma glucose concentrations similar to controls; however, at 20 and 60 min, A pups had significantly diminished glucose concentrations. Values were similar to those of controls at 120 min and remained so at 240 min (Fig. 5) . At 20 and 60 min A pups had significantly increased plasma insulin concentrations; at birth and after 60 min values were similar to controls (Fig. 5) . Plasma glucagon values. Values for control pups at 120 and 240 min significantly concentrations did not differ between A and control groups at exceeded those of A pups (Table 2) . any point.
GESTATION (days)
Hepatic glycogen concentrations were significantly elevated in A compared to controls at 20 and 60 min. At birth, 120, and DISCUSSION 240 min, A glycogen concentrations were similar to controls Reducing litter number in each uterine horn by approximately ( Table 3) . In control pups, hepatic cytosolic PEPCK activity at 50% during the latter third of gestation accelerates the growth of 120 and 240 min was significantly increased compared to earlier the remaining fetuses. Although our study did not identify all of 
randomly selected a pup from each litter by assigning a number to each Fig. 3 . Growth of fetal brain and liver in A and control litters. From pup of a litter and using a random number table to select one. This pup's day 18 to birth, fetuses of A litters had significantly increased brain and newborn body mass was significantly related to the number of pups in liver mass ( p < 0.001).
its litter (r = -0.823, n = 40, p < 0.001). * Differences between groups on specified day of gestation, p < 0.0 1 to 0.001. the factors responsible for this, it does suggest that selective artery ligation may increase glucose provision to surviving fetuses with subsequent stimulation of insulin secretion. A surprising finding was the development of hyperinsulinemia associated with hypoglycemia in newborn pups of ablated litters.
Under normal circumstances, the relation between litter size and fetal growth is limited. A roughly significant negative correlation exists between body weight and naturally occumng litter number in the rat when litters ranging from two to 17 fetuses are considered (3) . When the upper and lower extremes of litter size are excluded, this relation is no longer demonstrable (3, 13) . It is thus not surprising that these variables were not significantly related in our control litters of eight to 14 fetuses.
However, artificial restriction of litter size not only enhances the growth of the remaining fetuses but results in a strongly significant negative correlation between fetal number and body growth. The mean birth weight of the term pups of our A litters not only significantly exceeded that of controls but was also considerably greater than that reported for fetuses of naturally occumng litters (3, 13, 14) . The enhancing effect of A on fetal growth is also confirmed by the observation that the mean weight of pups in litters orignally 12 to 14 reduced to six and seven significantly exceeded that of control pups with naturally occurring litters of eight.
As reported in other models of accelerated intrauterine growth (5, 6), the A fetuses had significantly heavier placentas than controls. That is consistent with the general observation that fetal and placental growth parallel one another. We speculate that the increased placental mass may have resulted from enhanced blood flow to the placenta as a result of vessel ligation. It probably also represents the increased functional state of the placenta under these conditions. Studies in the guinea pig (1 5), rabbit (1 6), and rat (1 7) have demonstrated a relation between uteroplacental blood flow and fetal growth. Uteroplacental blood flow directly influences metabolic fuel provision and gaseous exchange to the fetus (18) . Inasmuch as we did not measure uteroplacental blood flow, we can only speculate if selective artery ligation increased blood flow to the remaining fetuses. Arteriovenous blood gas tensions and pH did not differ between A and control fetuses. This does not negate the possibility of increased blood flow in A litters because the partial pressure of gases and pH should not necessarily increase with greater than normal blood flow. However, the increased plasma glucose concentrations and fetallmaternal glucose ratios in the surviving fetuses of A litters suggest that blood flow and glucose provision were enhanced to these fetuses. The increased plasma insulin and hepatic glycogen concentrations and diminished glucagon concentrations also indicate that increased glucose provision to the fetus rather than stimulated endogenous fetal glucose production was responsible for the increase in fetal plasma glucose concentrations. On days 18 and 19, glucose was available in sufficient quantity not only to enhance growth but also to increase hepatic glycogen deposition significantly. The fact that hepatic glycogen and insulin concentrations were not increased on days 20, 2 1, and at birth suggests that maternal glucose provision was decreased compared to days 18 and 19; however, the amount of glucose provided was SUEcient to sustain an increased rate of body growth. In this regard, Fletcher et al. (19) reported that rabbit fetuses whose growth had been increased by reduction of litter size had increased insulin concentrations on day 30 of the rabbit's 32-day gestation. Our data, as theirs, indicate a link between alterations in litter size, a physical variable responsible for fetal growth, with changes in fetal metabolism.
Insulin is an important stimulator of fetal growth. Fetal hyperinsulinemia accelerates the growth of adipose, hepatic, muscle, and connective tissues (1, 2) . The increased glucose availability in A fetuses stimulated insulin secretion, thereby enhancing the growth of liver and carcass. This insulin effect is confirmed by the increased hepatic glycogen concentrations on these days. The increased protein and DNA concentrations in livers of A fetuses suggest that the increased growth of this organ resulted from both cellular hypertrophy and hyperplasia. Inasmuch as we were unable to obtain adequate fetal plasma samples from day 15 to 17, it is unclear if glucose and insulin concentrations were increased before day 18. The observations that fetal P-cell secretion of insulin is sluggish in response to secretogogue stimulation (20) and that plasma insulin was already elevated in A fetuses on day 18 suggest that provision of plasma glucose and perhaps other metabolic fuels might have already been increased before this time.
Although these observations indicate an important role for increased glucose and insulin availability in stimulating the growth of A fetuses, other unidentified factors were probably also important. On days 20 and 2 1, fetal plasma glucose and insulin availability had returned to control levels in A fetuses. This resulted in hepatic glycogen concentrations in the normal range. Despite this, the body mass of A fetuses continued to be significantly greater than controls and their rate of growth was similar to that between days 18 and 19. Also, from days 18 to birth, brain growth was significantly increased in A fetuses. Whereas it has been demonstrated that the rat brain has insulin receptors (2 I), and insulin administered in the physiologic range stimulates the synthesis of specific macromolecules and RNA (22) , no studies have demonstrated that insulin stimulates actual brain growth. The A fetuses and pups had increased brain DNA and protein concentrations suggesting that litter reduction in some unknown manner stimulates both brain hyperplasia and hypertrophy. This phenomenon has been reported in other models of fetal A (5, 6, 23, 24) . These observations indicate that growthpromoting factors other than insulin were operating in A fetuses.
Several methods for accelerating fetal growth by reducing litter size have been described. Ligation of one uterine horn in the rat before conception (23) , needle aspiration of fetuses in rabbits ( 3 , and crushing (25) or electrocautery (6) of fetuses have all been reported to accelerate the growth of surviving fetuses. The studies reporting these techniques used limited numbers of animals and did not control for the potential effect of litter number on fetal growth. Inasmuch as the reproducibility of these techniques was not reported, it is difficult to assess their potential usefulness. Because of these concerns, we matched each experimental litter to a control having the same number of fetuses. A very few of these had a fetal resorption. The 93% success rate indicates that selective vessel ligation on day 14 is quite reproducible. Our experience concurs with that of others indicating that when fewer than 50% of fetuses in the rat are killed, the growth of the surviving fetuses is less likely to be enhanced. Although reducing litter size more than 50% is associated with accelerated growth, this also increases fetal loss. For these reasons, we believe that litter reduction by 50% on day 14 is a good method to accelerate growth.
Although control pups demonstrated the expected increase in plasma glucose concentration at 20 min of neonatal life, A pups had significantly diminished values at this and 60 min. This hypoglycemia resulted in part from elevated plasma insulin concentrations that limited hepatic glycogen mobilization. Glucagon secretion did not increase possibly as a result of the transient nature of the hypoglycemia and the sluggish response of the neonatal alpha cell to glucose (26) . In the rat and other species, glucagon stimulates while insulin delays the induction of hepatic cytosolic PEPCK, a critical gluconeogenic enzyme in the newborn rat (27) . The normal increase in glucagon and decrease in insulin in the newborn rat are important to induce this enzyme and facilitate glucose production (27, 28) . The elevations of insulin and lack of increase of glucagon in hypoglycemic A newborns may have delayed PEPCK induction thereby contributing to hypoglycemia in A newborns.
The significant elevations of plasma insulin in A newborn pups is particularly difficult to explain because insulin concentrations in A fetuses were normal during the last days ofgestation. This phenomenon of neonatal hypoglycemia associated with increased body size is similar to the unexplained increased incidence of hypoglycemia that occurs in large for gestational age human neonates who are not infants of diabetic mothers (7, 29) . Neonatal hypoglycemia has also been observed in another model of accelerated fetal growth in the rat. Insulin injection in the rat fetus during late gestation stimulates fetal uowth and also results in neonatarhypgglycemia as a consequence of hyperinsulinemia (30, 3 1) . Such rats at 10 to 12 wk demonstrate delayed glucose clearance in response to glucose challenge (32) . The mechanisms for altered glucose homeostasis in these conditions remain to be delineated.
Ablation of fetuses with a 50% reduction in litter number will be useful for identifying and further characterizing the mechanisms responsible for accelerated intrauterine growth. It may also determine the causes of the hypoglycemia that often accompanies macrosomia in the neonatal period.
